Clarivate PLC
Closed
SectorTechnology
2.21 0.45
Overview
Share price change
24h
Min
2.18
Max
2.21
Income | -244M -40M |
|---|---|
Sales | -32M 586M |
EPS | 0.18 |
Profit margin | -6.866 |
Employees | 12,000 |
EBITDA | -16M 214M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +61.99% upside |
Next Earnings | 29 Jul 2026 |
|---|
Market Cap | -20M 1.6B |
|---|---|
Previous open | 1.76 |
Previous close | 2.21 |
Clarivate PLC Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Clarivate PLC Forecast
Price Target
By TipRanks
61.99% upside
12 Months Forecast
Average 3.58 USD 61.99%
High 6 USD
Low 2.4 USD
Based on 5 Wall Street analysts offering 12 month price targets forClarivate PLC - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Clarivate PLC
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
